ATwo-Centre Audit on Changes in Ejection Fraction (EF) following sequential anthracycline chemotherapy and Trastuzumab (T) in patients with HER2+ Early Breast Cancer (EBC). (March 2017) - Fernando, S.; Conway, A.; Mitchell, H.; Sandri, I.; Wardley, A.; Okonta, L.; Mansi, J.